Gemini cationic lipid-type nanovectors suitable for the transfection of therapeutic plasmid dna encoding for pro-inflammatory cytokine interleukin-12

N Sánchez-Arribas, M Martínez-Negro, C Aicart-Ramos… - Pharmaceutics, 2021 - mdpi.com
Ample evidence exists on the role of interleukin-12 (IL-12) in the response against many
pathogens, as well as on its remarkable antitumor properties. However, the unexpected …

Predictors of mortality in hospitalised patients with COVID-19: a 1-year case–control study

L Camacho-Domínguez, M Rojas, M Herrán… - BMJ open, 2024 - bmjopen.bmj.com
Background A paucity of predictive models assessing risk factors for COVID-19 mortality that
extend beyond age and gender in Latino population is evident in the current academic …

Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations

AA Varela, S Cheng, JH Werren - PeerJ, 2021 - peerj.com
Abstract Angiotensin-converting enzyme 2 (ACE2) is the cell receptor that the coronavirus
SARS-CoV-2 binds to and uses to enter and infect human cells. COVID-19, the pandemic …

Innate immune responses to SARS-CoV-2.

S Dawoodi, SAA Rizvi, AK Zaidi - Progress in Molecular Biology …, 2023 - europepmc.org
This chapter provides an overview of the innate immune response to SARS-CoV-2, focusing
on the recognition, activation, and evasion strategies employed by the virus. The innate …

[图书][B] Hydrogen-Oxygen Inhalation for Treatment of COVID-19: With Commentary from Zhong Nanshan

K Xu - 2020 - books.google.com
COVID-19 pneumonia is ravaging the world. Faced with the lack of specialized treatment, a
novel form of hydrogen-oxygen inhalation therapy has been successfully developed …

Pathogenesis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) respiratory infection

AS Olagunju, IP Oladapo, SO Kosemani… - International Journal of …, 2020 - ijtmgh.com
With the occurrence of a mysterious pneumonia in the Hubei province (Wuhan) of China in
December 2019, a different coronavirus, the severe acute respiratory syndrome coronavirus …

Post-COVID-19 prolonged neurological symptoms and characteristics: a face-to-face survey study

Z Yavuz, S Tezcan, M KUZU KUMCU, B Ölmez… - Neurology …, 2022 - avesis.ankara.edu.tr
© 2022, ASEAN Neurological Association. All rights reserved. Background: COVID-19 was
declared as a pandemic by World Health Organization on March 11, 2020, and still …

Alzheimer's Disease and COVID-19 Pathogenic Overlap: Implications for Drug Repurposing

M Golzari-Sorkheh, I Liyanage, MA Reed… - Canadian Journal of …, 2024 - cambridge.org
As COVID-19 continues, a safe, cost-effective treatment strategy demands continued inquiry.
Chronic neuroinflammatory disorders may appear to be of little relevance in this regard; …

RNA Coronaviruses' Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics

GARY Suaifan, BA Alkhawaja… - Mini reviews in …, 2022 - ingentaconnect.com
Coronaviruses are RNA-infective viruses that could be considered principal players in
universal high-profile outbreaks, namely the Severe Acute Respiratory Syndrome (SARS …

[PDF][PDF] The Potential of Hydroxysafflor Yellow A as an Adjuvant in COVID-19 Patients with Acute Respiratory Distress Syndrome.

L Hansur, JA Pawitan - International Medical Journal, 2021 - researchgate.net
The Potential of Hydroxysafflor Yellow A as an Adjuvant in COVID-19 Patients with Acute
Respiratory Distress Syndrome Page 1 INTRODUCTION Coronavirus disease 2019 (COVID-19) …